Amgen’s Prolia approved in the USA but …

On Tuesday, the US Food and Drug Administration (FDA) approved Amgen’s RANK-L inhibitor denosumab (Prolia®) for the treatment of postmenopausal women with osteoporosis at high risk for fracture. However, what they have not done (yet) … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,170 other followers